Comerica Bank’s Tarsus Pharmaceuticals TARS Stock Holding History

Comerica Bank’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$70K	Buy	855 +705	+470%	+$52.6K	﹤0.01%	2750
2025 Q3	$8.93K	Buy	150 +49	+49%	+$2.41K	﹤0.01%	3276
2025 Q2	$4.08K	Sell	101 -95	-48%	-$4.28K	﹤0.01%	3399
2025 Q1	$10.1K	Buy	196 +23	+13%	+$1.14K	﹤0.01%	3169
2024 Q4	$9.58K	Buy	173 +84	+94%	+$3.81K	﹤0.01%	3181
2024 Q3	$2.92K	Sell	89 -21	-19%	-$590	﹤0.01%	3430
2024 Q2	$2.99K	Buy	+110	New	+$3.7K	﹤0.01%	3400
2024 Q1	–	Sell	-57	Closed	-$1.15K	–	3824
2023 Q4	$1.15K	Buy	+57	New	+$952	﹤0.01%	3608

Other funds holding TARS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Comerica Bank's TARS Position: Q4 2025 in Review

Comerica Bank increased its Tarsus Pharmaceuticals (TARS) stake by 470% in Q4 2025, buying an estimated $52.6K and bringing the position to 855 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #2750.

Comerica Bank first reported a position in TARS in Q4 2023 and has held it in 8 quarters since. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

Comerica Bank held 855 shares of Tarsus Pharmaceuticals worth $70K as of Q4 2025.
Comerica Bank bought 705 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $52.6K.
Tarsus Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2750 holding.
Comerica Bank first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.